This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rifabutin‐based 10‐day and 14‐day triple therapy as a third‐line and fourth‐line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens?. Issue 3 (1st June 2016)
Record Type:
Journal Article
Title:
Rifabutin‐based 10‐day and 14‐day triple therapy as a third‐line and fourth‐line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens?. Issue 3 (1st June 2016)
Main Title:
Rifabutin‐based 10‐day and 14‐day triple therapy as a third‐line and fourth‐line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens?